Yasser Shaib
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yasser Shaib has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Anthony Kerbage
American University of Beirut Medical Center
2 shared publicationsAyman Alrazim
Division of Gastroenterology and Hepatology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
2 shared publicationsHani Tamim
American University of Beirut Medical Center
2 shared publicationsKassem Barada
American University of Beirut Medical Center
2 shared publicationsMaha Makki
American University of Beirut Medical Center
2 shared publicationsAdel Hajj Ali
American University of Beirut Faculty of Medicine, Bliss Street, Hamra, Beirut, Lebanon
1 shared publication
Latest Publications
- 5 January 2025
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 26 (1) , 67-70
Clinical features and temporal trends in H. pylori negative gastric maltoma
- 5 January 2025
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 26 (1) , 67-70
Clinical features and temporal trends in H. pylori negative gastric maltoma
- Open Access
- 30 March 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (7) , 1297
The Clinical Significance of Incidental GIT Uptake on PET/CT: Radiologic, Endoscopic, and Pathologic Correlation
Incidental gastrointestinal tract (GIT) [18F]-Fluorodeoxyglucose (FDG) uptake in positron emission technology/computed tomography (PET/CT) is an unexpected and often complicated finding for clinicians. This retrospective study reviewed 8991 charts of patients who underwent PET/CT: 440 patients had incidental GIT uptake, of which 80 underwent endoscopy. Patient characteristics, imaging parameters, and endoscopic findings were studied. Of the 80 patients, 31 had cancer/pre-cancer lesions (16 carcinomas; 15 pre-malignant polyps). Compared to patients with benign/absent lesions, patients with cancer/pre-cancer lesions were significantly older (p = 0.01), underwent PET/CT for primary evaluation/staging of cancer (p = 0.03), had focal GIT uptake (p = 0.04), and had lower GIT uptake (p = 0.004). Among patients with focal uptake, an SUVmax of 9.2 had the highest sensitivity (0.76) and specificity (0.885) in detecting cancer/pre-cancerous lesions. Lower GIT uptake was most common in the sigmoid colon, and upper GIT uptake was most frequent in the stomach. In a bivariate analysis, predictors of cancer/pre-cancer were older age, PET/CT indicated for primary evaluation, focal uptake, uptake in the lower GIT, and higher SUVmax. Further endoscopic investigation is warranted for patients with incidental GIT uptake, especially in the elderly or those presenting for primary evaluation with PET/CT, with the following findings on imaging: lower GIT uptake, focal uptake, or high SUVmax.
- 30 March 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (7) , 1297
Open AccessThe Clinical Significance of Incidental GIT Uptake on PET/CT: Radiologic, Endoscopic, and Pathologic Correlation
Incidental gastrointestinal tract (GIT) [18F]-Fluorodeoxyglucose (FDG) uptake in positron emission technology/computed tomography (PET/CT) is an unexpected and often complicated finding for clinicians. This retrospective study reviewed 8991 charts of patients who underwent PET/CT: 440 patients had incidental GIT uptake, of which 80 underwent endoscopy. Patient characteristics, imaging parameters, and endoscopic findings were studied. Of the 80 patients, 31 had cancer/pre-cancer lesions (16 carcinomas; 15 pre-malignant polyps). Compared to patients with benign/absent lesions, patients with cancer/pre-cancer lesions were significantly older (p = 0.01), underwent PET/CT for primary evaluation/staging of cancer (p = 0.03), had focal GIT uptake (p = 0.04), and had lower GIT uptake (p = 0.004). Among patients with focal uptake, an SUVmax of 9.2 had the highest sensitivity (0.76) and specificity (0.885) in detecting cancer/pre-cancerous lesions. Lower GIT uptake was most common in the sigmoid colon, and upper GIT uptake was most frequent in the stomach. In a bivariate analysis, predictors of cancer/pre-cancer were older age, PET/CT indicated for primary evaluation, focal uptake, uptake in the lower GIT, and higher SUVmax. Further endoscopic investigation is warranted for patients with incidental GIT uptake, especially in the elderly or those presenting for primary evaluation with PET/CT, with the following findings on imaging: lower GIT uptake, focal uptake, or high SUVmax.
- Open Access
- 15 August 2022
- Published by Springer Nature in Research Square
Gastrointestinal bleeding during the COVID-19 pandemic: More severe and less clear
Background The COVID-19 pandemic has led patients to avoid medical care, and hospitals to limit high-risk procedures. Methods We conducted a cohort study to assess the impact of the COVID-19 pandemic on the presentation and outcomes of gastrointestinal bleeding (GIB). Results Patients admitted during the pandemic were more likely to present with severe hemorrhage and to have a drop of hemoglobin ≥ 2g/dL. The origin of GIB was also more likely to remain unknown. Admission during the pandemic was an independent predictor of severe hemorrhage (HR = 2.08, [1.07–4.05]). Conclusion During the COVID-19 pandemic, patients with GIB were more likely to present with more severe hemorrhage.
- 15 August 2022
- Published by Springer Nature in Research Square
Open AccessGastrointestinal bleeding during the COVID-19 pandemic: More severe and less clear
Background The COVID-19 pandemic has led patients to avoid medical care, and hospitals to limit high-risk procedures. Methods We conducted a cohort study to assess the impact of the COVID-19 pandemic on the presentation and outcomes of gastrointestinal bleeding (GIB). Results Patients admitted during the pandemic were more likely to present with severe hemorrhage and to have a drop of hemoglobin ≥ 2g/dL. The origin of GIB was also more likely to remain unknown. Admission during the pandemic was an independent predictor of severe hemorrhage (HR = 2.08, [1.07–4.05]). Conclusion During the COVID-19 pandemic, patients with GIB were more likely to present with more severe hemorrhage.
- Open Access
- 21 June 2022
- Published by Springer Nature in BMC Gastroenterology
- Vol. 22 (1) , 1-6
Validation of the new ABC score for predicting 30-day mortality in gastrointestinal bleeding
Background/Aim: The ABC score is a new pre-endoscopic scoring system that was recently developed to accurately predict one-month mortality in upper and lower gastrointestinal bleeding (GIB). We aim to validate this new score on a cohort of Lebanese patients treated in a tertiary care center and to compare it to currently existing scores. Methods: Adult patients admitted to the American University of Beirut Medical Center (AUBMC) with overt GIB between January 2013 and August 2020 were included. The area under receiver operating characteristic (AUROC) curves of the ABC score in predicting 30-day mortality was calculated using the SPSS software. Other optimal existing scores for predicting mortality (the Oakland score for lower GIB, the AIMS-65 and the Rockall scores for upper GIB)s were also assessed and compared to the ABC score. Results: A total of 310 patients were included in our study. For upper GIB, the ABC score showed good performance in predicting 30-day mortality (AUROC: 0.79), outperforming both the AIMS-65 score (AUROC 0.67, p < 0.001) and the Rockall score (AUROC: 0.62, p < 0.001). For lower GIB, the ABC score also had good performance which was comparable to the Oakland score (AUROC: 0.70 vs 0.56, p = 0.26). Conclusion: In our cohort of patients, the ABC score demonstrated good performance in predicting 30-day mortality for patients with upper and lower GIB compared to other established risk scores, which may help guide management decisions. This simple and novel score provides valuable prognostic information for patients presenting with GIB and appears to be reproducible in different patient populations.
- 21 June 2022
- Published by Springer Nature in BMC Gastroenterology
- Vol. 22 (1) , 1-6
Open AccessValidation of the new ABC score for predicting 30-day mortality in gastrointestinal bleeding
Background/Aim: The ABC score is a new pre-endoscopic scoring system that was recently developed to accurately predict one-month mortality in upper and lower gastrointestinal bleeding (GIB). We aim to validate this new score on a cohort of Lebanese patients treated in a tertiary care center and to compare it to currently existing scores. Methods: Adult patients admitted to the American University of Beirut Medical Center (AUBMC) with overt GIB between January 2013 and August 2020 were included. The area under receiver operating characteristic (AUROC) curves of the ABC score in predicting 30-day mortality was calculated using the SPSS software. Other optimal existing scores for predicting mortality (the Oakland score for lower GIB, the AIMS-65 and the Rockall scores for upper GIB)s were also assessed and compared to the ABC score. Results: A total of 310 patients were included in our study. For upper GIB, the ABC score showed good performance in predicting 30-day mortality (AUROC: 0.79), outperforming both the AIMS-65 score (AUROC 0.67, p < 0.001) and the Rockall score (AUROC: 0.62, p < 0.001). For lower GIB, the ABC score also had good performance which was comparable to the Oakland score (AUROC: 0.70 vs 0.56, p = 0.26). Conclusion: In our cohort of patients, the ABC score demonstrated good performance in predicting 30-day mortality for patients with upper and lower GIB compared to other established risk scores, which may help guide management decisions. This simple and novel score provides valuable prognostic information for patients presenting with GIB and appears to be reproducible in different patient populations.
- Open Access
- 29 April 2022
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 16, 1380
Pancreatic cancer in the MENA region, a bibliometric review
Pancreatic cancer in the MENA region, a bibliometric review Hasan Nassereldine1*a, Hussein Awada1*b, Adel Hajj Ali1*c, Mohammad Zeineddine1, Zahy Abdul Sat
- 29 April 2022
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 16, 1380
Open AccessPancreatic cancer in the MENA region, a bibliometric review
Pancreatic cancer in the MENA region, a bibliometric review Hasan Nassereldine1*a, Hussein Awada1*b, Adel Hajj Ali1*c, Mohammad Zeineddine1, Zahy Abdul Sat
- 15 May 2019
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 30 (5) , 461-466
Intragastric balloon treatment of obesity: Long-term results and patient satisfaction
Background/Aims: Intragastric balloon (IGB) treatment of obesity is a minimally invasive outpatient procedure that has been shown to help weight loss in some patients. The aim of this study is to analyze the long-term results regarding the effectiveness, tolerability, and patient satisfaction in a cohort of patients undergoing the IGB insertion. Materials and Methods: Using a retrospective cohort study design, patients who had their IGB inserted/removed between the years 2009 and 2016 were contacted by phone and asked to answer a short questionnaire. The baseline characteristics, pre- and post- IGB weight, as well as their current weight were recorded. Different parameters of satisfaction were noted in addition to whether patients resorted to alternative weight-reduction measures. Results: Ninety-nine eligible patients were contacted, and 65 consented to the study. The average weight loss achieved at the end of the treatment period (3 to 10 months) was approximately a 12% decrease from the baseline. Only 39% of patients were satisfied with the procedure, and less than 50% were satisfied with the weight loss achieved. When assessing the long-term follow-up, years after the IGB removal (3.3±1.76 years), the vast majority of patients (78.7%) regained weight or resorted to further bariatric measures. Conclusion: IGB leads to weight loss among most patients, but it does not appear to fulfill patients’ expectations. Further, the initial weight loss is not sustainable over time. Cite this article as: El Haddad A, Rammal MO, Soweid A, et al. Intragastric balloon treatment of obesity: Long-term results and patient satisfaction. Turk J Gastroenterol 2019; 30(5): 461-6.
- 15 May 2019
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 30 (5) , 461-466
Intragastric balloon treatment of obesity: Long-term results and patient satisfaction
Background/Aims: Intragastric balloon (IGB) treatment of obesity is a minimally invasive outpatient procedure that has been shown to help weight loss in some patients. The aim of this study is to analyze the long-term results regarding the effectiveness, tolerability, and patient satisfaction in a cohort of patients undergoing the IGB insertion. Materials and Methods: Using a retrospective cohort study design, patients who had their IGB inserted/removed between the years 2009 and 2016 were contacted by phone and asked to answer a short questionnaire. The baseline characteristics, pre- and post- IGB weight, as well as their current weight were recorded. Different parameters of satisfaction were noted in addition to whether patients resorted to alternative weight-reduction measures. Results: Ninety-nine eligible patients were contacted, and 65 consented to the study. The average weight loss achieved at the end of the treatment period (3 to 10 months) was approximately a 12% decrease from the baseline. Only 39% of patients were satisfied with the procedure, and less than 50% were satisfied with the weight loss achieved. When assessing the long-term follow-up, years after the IGB removal (3.3±1.76 years), the vast majority of patients (78.7%) regained weight or resorted to further bariatric measures. Conclusion: IGB leads to weight loss among most patients, but it does not appear to fulfill patients’ expectations. Further, the initial weight loss is not sustainable over time. Cite this article as: El Haddad A, Rammal MO, Soweid A, et al. Intragastric balloon treatment of obesity: Long-term results and patient satisfaction. Turk J Gastroenterol 2019; 30(5): 461-6.
- 23 October 2017
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 24 (11) , 637-642
Preoperative biliary drainage for malignant biliary obstruction: results from a national database
Background: The impact of preoperative biliary drainage (PBD) on postoperative morbidity and mortality in patients with malignant biliary obstruction is still unclear. We examined short‐term surgical outcomes among drained and non‐drained patients.Methods: Patients who underwent surgical resection for their malignancies with biliary obstruction were identified using the American College of Surgeons National Surgical Quality Improvement Program Participant Use Files from 2014 to 2015. Mortality and morbidity were compared among patients who had PBD to those who did not undergo biliary drainage prior to surgery.Results: A total of 2,306 patients were included; of these 1,803 (77.8%) had PBD. The postoperative mortality was 3.0% and 2.2% among direct surgery (DS) group and PBD group, respectively (P = 0.3). Postoperative complications were higher in the PBD group compared to the DS group (27.1% vs. 19.5%; P = 0.0005). Patients in the PBD group had higher risk of sepsis (13.5% vs. 7.2%; P = 0.0001), wound infections (16.5% vs. 10.9%; P = 0.002) and pancreatic fistula (17.5% vs. 12.4%; P = 0.006) compared to the DS group.Conclusion: Preoperative biliary drainage is associated with increased risk of sepsis and wound infections, but does not impact the postoperative mortality of patients undergoing PBD.
- 23 October 2017
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 24 (11) , 637-642
Preoperative biliary drainage for malignant biliary obstruction: results from a national database
Background: The impact of preoperative biliary drainage (PBD) on postoperative morbidity and mortality in patients with malignant biliary obstruction is still unclear. We examined short‐term surgical outcomes among drained and non‐drained patients.Methods: Patients who underwent surgical resection for their malignancies with biliary obstruction were identified using the American College of Surgeons National Surgical Quality Improvement Program Participant Use Files from 2014 to 2015. Mortality and morbidity were compared among patients who had PBD to those who did not undergo biliary drainage prior to surgery.Results: A total of 2,306 patients were included; of these 1,803 (77.8%) had PBD. The postoperative mortality was 3.0% and 2.2% among direct surgery (DS) group and PBD group, respectively (P = 0.3). Postoperative complications were higher in the PBD group compared to the DS group (27.1% vs. 19.5%; P = 0.0005). Patients in the PBD group had higher risk of sepsis (13.5% vs. 7.2%; P = 0.0001), wound infections (16.5% vs. 10.9%; P = 0.002) and pancreatic fistula (17.5% vs. 12.4%; P = 0.006) compared to the DS group.Conclusion: Preoperative biliary drainage is associated with increased risk of sepsis and wound infections, but does not impact the postoperative mortality of patients undergoing PBD.